Los Angeles Capital Management LLC purchased a new position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 225,517 shares of the company’s stock, valued at approximately $1,660,000. Los Angeles Capital Management LLC owned approximately 0.31% of SIGA Technologies as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Gladius Capital Management LP acquired a new position in shares of SIGA Technologies in the 4th quarter valued at $32,000. UBS Group AG boosted its holdings in shares of SIGA Technologies by 30.3% in the 2nd quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after buying an additional 1,070 shares in the last quarter. Wipfli Financial Advisors LLC acquired a new position in shares of SIGA Technologies in the 3rd quarter valued at $50,000. Cambridge Investment Research Advisors Inc. acquired a new position in shares of SIGA Technologies in the 3rd quarter valued at $105,000. Finally, Royal Bank of Canada boosted its holdings in shares of SIGA Technologies by 338.6% in the 3rd quarter. Royal Bank of Canada now owns 10,771 shares of the company’s stock valued at $111,000 after buying an additional 8,315 shares in the last quarter. Institutional investors and hedge funds own 39.44% of the company’s stock.
SIGA Technologies Trading Down 0.2 %
Shares of SIGA Technologies stock opened at $5.82 on Tuesday. The company has a fifty day simple moving average of $5.91 and a 200-day simple moving average of $7.35. SIGA Technologies, Inc. has a 12-month low of $5.11 and a 12-month high of $26.99. The stock has a market cap of $414.78 million, a price-to-earnings ratio of 12.65 and a beta of 0.83.
About SIGA Technologies
SIGA Technologies, Inc is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses.
Recommended Stories
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- Insiders Drive Volatility For Keurig Dr Pepper
- After a 40% Drop, Analysts Remain Bullish on Impinj
- Visa Charges Higher After Better-Than-Expected Q2 Report
- onsemi Puts A Bottom in Chip Stocks, Heads For New Highs
- Can Teladoc Stock Be Resuscitated?
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.